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Abstract
Background: This prospective randomized blinded clinical study aimed to investigate the potential of vedaprofen
for preventive analgesia, comparing its analgesic effects with ketoprofen administered post-operatively in dogs
undergoing maxillectomy or mandibulectomy.
Results: Pain control was effective and rescue analgesia was not necessary in any group. Pain scores were not
significantly different between groups. The respiratory rate and rectal temperature were decreased in all groups at
extubation until 6 hours post-extubation compared to baseline. Cortisol and epinephrine levels were increased only
at 0.5 hours after extubation in all groups compared to baseline.
Conclusions: Vedaprofen did not present any preventive analgesic effect. Pre- and postoperative vedaprofen were
as effective as ketoprofen for postoperative pain control.
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Background
Acute pain treated inappropriately after surgery can be
magnified and has the potential to develop into a long-
term postoperative pain as a result of central sensi-
tization, which is much more difficult to manage [1,2].
Preventive analgesia consists of all perioperative efforts
to decrease pain and minimize consumption of analge-
sics in the postoperative period. This seems to be the
most effective means of decreasing postoperative pain,
because surgical incision alone is not the only trigger for
central sensitization. Other factors, such as preoperative
pain and additional painful noxious intraoperative inputs
such as retraction, as well as postoperative inflammatory
processes, can all result in the development of an altered
central processing of afferent input, which, in turn, is
capable of amplifying subsequent postoperative nocicep-
tive input [3]. The emphasis of preventive analgesia is on
the pathophysiologic phenomenon that should prevent
altered sensory processing, and thus investigation of a
preventive analgesic effect requires comparison of two
groups of patients receiving identical treatments that had
been started before and after surgery, respectively [1].
The concept of preventive analgesia was founded on
experimental studies of pre-emptive analgesia in animal
models of pain [4,5]. Pre-emptive analgesia is an inter-
vention given before incision or surgery that it is more
effective than the same treatment administered after in-
cision or surgery. There are only a few investigations
fundamentally designed for comparing the pre- versus
postoperative administration in veterinary patients [6,7].
In humans, the pre-emptive epidural analgesia with
opioids or local anesthetics induces consistent postoper-
ative improvements, and the pre-emptive infiltration of
wounds with local anesthetic improves analgesic con-
sumption and time for the first rescue analgesic request
[1]. Non-steroidal anti-inflammatory drugs (NSAIDs)
also can improve some aspects of postoperative pain
when given before surgery compared to the administra-
tion after surgery in humans [8-11] and dogs [6,7]. The
NSAIDs inhibit peripheral and central prostaglandin
synthesis, which reduces the inflammation that accom-
panies tissue injury, in addition to the attenuation of the
response to noxious stimuli [12].
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Vedaprofen is a NSAID that can control pain and in-
flammation associated with clinical and experimental
musculoskeletal disorders in dogs [13-15]. It is available
as a palatable gel formulation, which has a rapid and al-
most complete absorption after oral administration in
dogs. The oral route has a terminal half-live of the same
order of magnitude of the intravenous administration
[16], but with the advantage that the oral route is less
stressful to the animal and can be easily administered by
the owner during postoperative home care [17]. Veda-
profen is known to preferentially inhibit the cyclo-
oxygenase-2 in dogs [18], and it is apparently safe in this
species, as there was a low incidence of gastrointestinal
changes, like vomiting and diarrhea after a long-term
treatment for 30–56 days [13,14].
Although vedaprofen has proved to be an effective an-
algesic for postoperative pain control in dogs, no studies
have investigated if the sublingual preoperative adminis-
tration has a superior analgesic effect over the admi-
nistration after surgery on postoperative pain control in
this species. Therefore, the aim of this prospective, ran-
domized, double-blind study, was to investigate whether
sublingual vedaprofen given before was more effective
than that given after surgery for decreasing postoperative
pain intensity and analgesic consumption in dogs un-
dergoing maxillectomy and mandibulectomy. Since the
analgesic effect of sublingual vedaprofen was never as-
sessed in dogs undergoing maxillectomy and man-
dibulectomy, we included a control group consisting of
animals receiving ketoprofen, a NSAID known to pro-
vide adequate postoperative analgesia for this surgical
procedure in this species [19]. Our hypothesis was that
the preoperative administration of vedaprofen would
reduce postoperative pain and analgesic requirements
more than would vedaprofen or ketoprofen given after
surgery.
Results
There were no significant differences among groups in
terms of the study population. No significant differences in
the duration of surgery (65 ± 8 minutes in the PRE group,
47 ± 7 minutes in the POST group and 50 ± 4 minutes in
the control group) and time for extubation (4 ± 1 minutes
in the PRE group, 3 ± 1 minutes in the POST group and
4 ± 1 minutes in the Control) were observed among
groups. Mechanical ventilation was not necessary in any
group. No clinical complications or adverse effects were
observed during recovery from anesthesia in any group.
In both groups, epinephrine and cortisol levels were
significantly increased at 30 minutes after extubation
compared to baseline (P < 0.05; Figures 1 and 2). Plasma
norepinephrine and dopamine concentrations and pain
and sedation scores were not significantly different
within or among groups. There were no differences in
analgesia or sedation scores within the groups or among
them and rescue analgesia was not necessary in any dog
(Figures 3 and 4). The highest scores in the NRS and
CPSS were, respectively, 3.9 and 1.3 at 2.5 h in the PRE
group; 3.7 and 1.7 at 4.5 h in the POST group and; 3.3 at
20 h and 0.8 at 30 minutes in the Control group.
Heart rate did not vary significantly throughout the
study in any group. In the POST and control groups, the
MAP (mean arterial pressure) was significantly decreased
at extubation and at 30 minutes after extubation com-
pared to baseline (P < 0.05). At 24 hours after extubation,
the MAP was significantly increased (P < 0.05) and de-
creased (P < 0.05) compared with baseline in the POST
and Control groups, respectively. The respiratory rate (fR)
was significantly decreased at extubation and at 30 mi-
nutes, 2.5 h, 4.5 h and 6 h after extubation compared to
baseline in all groups (P < 0.05). In the control group, the
fR was maintained significantly decreased at 20 h and 24 h
after extubation compared with baseline and compared
with PRE and POST groups at the corresponding time-
points (P < 0.05). The rectal temperature was significantly
Figure 1 Plasma epinephrine levels (mean ± SEM). PRE dogs
were treated with preemptive vedaprofen, POST dogs were treated
with postoperative vedaprofen, Control dogs were treated with
postoperative ketoprofen; *within a treatment, value differs significantly
(P < 0.05) from the baseline value.
Figure 2 Serum cortisol (mcg.mL−1) (mean ± SEM). PRE dogs
were treated with preemptive vedaprofen, POST dogs were treated
with postoperative vedaprofen, Control dogs were treated with
postoperative ketoprofen; *within a treatment, value differs significantly
(P < 0.05) from the baseline value.
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decreased at extubation, which was maintained until 4 h
(POST group) and 6 h (PRE and control groups) after
extubation compared to baseline (P < 0.05). Heart rate,
MAP, fR, and rectal temperature values were always within
the range of normal values for the species (Table 1).
Discussion
The main finding of the present study was that the pre-
operative administration of sublingual vedaprofen was as
effective as the postoperative administration for postop-
erative pain control, indicating that vedaprofen had no
Figure 3 Mean (SD) postoperative pain numerical rating scale (NRS). PRE dogs were treated with preemptive vedaprofen, POST dogs were
treated with postoperative vedaprofen, Control dogs were treated with postoperative ketoprofen.
Figure 4 Mean (SD) postoperative pain Colorado Pain Scoring System (CPSS). PRE dogs were treated with preemptive vedaprofen, POST
dogs were treated with postoperative vedaprofen, Control dogs were treated with postoperative ketoprofen.
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preventive analgesic effect in the present study. Regard-
less of the time of administration, vedaprofen given
through the sublingual route was associated with low
pain scores and was as effective as ketoprofen for con-
trolling postoperative pain in dogs undergoing maxillec-
tomy and mandibulectomy.
Vedaprofen was chosen in the present study based on
pilot registers made up on the authors’ experience. The
dosing was the one recommended by a pharmacokinetic
study of vedaprofen in dogs, describing that absorption
of vedaprofen is rapid and almost complete after oral ad-
ministration, which is followed by a terminal half-live of
the same order of magnitude of the intravenous admin-
istration [16]. In the present study, the advantages of
using the sublingual route were that one did not have to
force the animal to swallow the medication and the ab-
sorption of the drug was ensured even in dogs that did
not have a swallow reflex (unconscious anesthetized).
Vomiting was not observed in the present study, but the
sublingual route would be another advantage over the
oral route in these cases. The sublingual route was
proven to be effective on absorbing vedaprofen, because
both pre- and postoperative strategies resulted in pain
scores as low as with ketoprofen, a NSAID known to be
effective for controlling postoperative pain in dogs
undergoing maxillectomy and mandibulectomy [19]. A
group of dogs receiving ketoprofen was used as control
due to ethical reasons, considering that the use of a pla-
cebo group is unfeasible in a study whose main objective
is to find the best method to provide pain relief.
Among all analgesic agents used routinely, the NSAIDs
are the less likely to block central sensitization resulting
from surgery, since they primarily act peripherally by
blocking the release of mediators that have been found to
sensitize peripheral nociceptors, thus, leading to a re-
duction in inflammation and pain perception [20]. Even
though, a previous study [6] found that dogs receiving car-
profen, a NSAID, were awarded lower pain scores during
the first postoperative hour than the group of dogs that re-
ceived carprofen at the end of the surgery for a variety of
orthopedic and soft tissue procedures. Therefore, one of
the reasons for the lack of a preventive analgesic effect
could be attributed to the fact that vedaprofen was admi-
nistered in animals that were already experiencing some
pain, considering the discomfort induced by the back-
ground disease that led to the indication for the surgical
treatment. The crucial point in preventive analgesia stra-
tegies focuses in the administration of the analgesic before
pain emerges, more than simply before surgical incision
[3]. Accordingly, a previous study found a preventive
analgesic effect of carprofen in dogs with no background
painful disease that were anesthetized for elective ovario-
hysterectomy [7]. In another study, the authors did not
find a preventive analgesic effect of carprofen in dogs with
femoral or pelvic fractures, even though they had received
the NSAID before surgical incision [21].
Alternatively, a preventive effect could have been re-
vealed beyond the period covered by vedaprofen after a
single administration (24 hours) [16]. This is because a
study in human patients found that 86% of the patients
who received preemptive epidural analgesia with opioids
and local anesthetics were pain free at 9.5 weeks, in
comparison with only 47% of the control patients [22].
This analgesic approach is more likely to block central
sensitization because it is delivered directly into the epi-
dural space. However, it was less likely to observe an
Table 1 Vital parameters (mean ± SD)
Parameter Group Baseline Extubation Time after surgery
30 min 2.5 h 4.5 h 6 h 20 h 24 h
HR PRE 37 ± 8 129 ± 9 136 ± 12 139 ± 9 138 ± 10 136 ± 11 136 ± 11 125 ± 9
(beats.minute−1) POST 138 ± 8 140 ± 12 137 ± 11 127 ± 9 128 ± 7 128 ± 7 124 ± 7 122 ± 6
Control 122 ± 6 138 ± 9 141 ± 12 146 ± 6 127 ± 11 125 ± 10 136 ± 10 121 ± 10
fR PRE 38 ± 7 24 ± 4* 18 ± 2* 27 ± 6* 21 ± 3* 20 ± 2* 36 ± 6 35 ± 6
(breaths.minute−1) POST 43 ± 6 25 ± 4* 19 ± 1* 18 ± 1* 19 ± 2* 21 ± 3* 37 ± 7 36 ± 7
Control 38 ± 5 24 ± 2* 21 ± 3* 17 ± 3* 15 ± 1* 21 ± 2* 25 ± 4* 18 ± 1*†‡
MAP PRE 94 ± 7 83 ± 6 86 ± 6 85 ± 6 91 ± 8 94 ± 5 106 ± 4 91 ± 6
(mmHg) POST 107 ± 5 87 ± 7* 95 ± 5* 98 ± 5 96 ± 4 109 ± 5 109 ± 5 114 ± 4†
Control 105 ± 4 81 ± 3* 84 ± 5* 97 ± 6 94 ± 3 92 ± 3 96 ± 6 89 ± 6‡
Temperature PRE 39.3 ± 0.2 37.1 ± 0.2* 36.9 ± 0.2* 37.5 ± 0.2* 37.8 ± 0.2* 38.1 ± 0.3* 39.2 ± 0.2 38.8 ± 0.2
(°C) POST 39.2 ± 0.2 37.0 ± 0.3* 37.2 ± 0.3* 37.6 ± 0.3* 37.9 ± 0.2* 38.5 ± 0.2 39.2 ± 0.2 38.8 ± 0.2
Control 38.9 ± 0.1 36.5 ± 0.3* 36.7 ± 0.2* 37.3 ± 0.3* 37.6 ± 0.2* 37.8 ± 0.2* 39.2 ± 0.2 39.1 ± 0.2
HR Heart rate, fR respiratory rate, MAP mean arterial pressure, PRE dogs treated with preemptive vedaprofen, POST dogs treated with postoperative vedaprofen,
Control dogs treated with postoperative ketoprofen; *within a treatment, value differs significantly (P < 0.05) from the baseline value; †within a time-point, values
are significantly different (P <0.05) from the PRE group; ‡within a time-point, values are significantly different (P <0.05) from the POST group.
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improvement in pain control after long-term treatment
with vedaprofen, considering that NSAIDs act reducing
inflammation peripherally and, therefore, are expected
to be more effective in the acute postoperative phase.
Another explanation for our findings could be attri-
buted to the subjective judgment of pain scores. Since
pain represents an unpleasant sensory and emotional
experience, a direct measurement of a subjective expe-
rience is challenging and imposes difficulties, especially
when evaluating it with a single tool. Therefore, in order
to minimize variations, pain was assessed using two
scoring systems in the present study. In addition, objec-
tive evaluations, such as physiological data, and serum
cortisol, epinephrine, norepinephrine and dopamine were
measured as indirect measurements of pain, in order to
reduce the subjective nature of the pain scores. The stress
caused by a painful stimulus can increase heart rate, MAP,
fR and serum cortisol and catecholamine levels [23].
Therefore, it is unlikely that the postoperative decrease in
fR and temperature compared to baseline was a response
to pain. In fact, these changes were found in all groups,
suggesting they were attributed to the residual effects of
isoflurane, rather than caused by differences in the NSAID
used or in the time they were administered [24]. Less
likely explanations could be the residual effects of acepro-
mazine or an increased fR and temperature at baseline
caused by fear and stress experienced prior to the pre-
anesthetic medication [25].
The preoperative vedaprofen induced no significantly
differences in the serum cortisol and catecholamine
levels compared to the postoperative administration. In
both groups, the norepinephrine and dopamine concen-
trations did not vary significantly throughout the study,
which is in accordance with the other measurements.
Nevertheless, both groups had increased cortisol and
epinephrine levels at 30 minutes post-extubation com-
pared to baseline. This was the only pain indicative in
the present study and it was not in-line with the changes
observed in pain scores and physiological variables. The
cortisol levels, however, were similar to a previous study
that found an effective pain control in dogs receiving
tramadol, codeine, ketoprofen alone or in combination
for the same type of oral orthopedic surgical procedures
[19]. Therefore, the changes on cortisol and epinephrine
were attributed to a stress response that probably was
not caused by pain. For instance, the stress caused by a
different environment (e.g. veterinary hospital, cage) is
capable of activating the pituitary-adrenal system in dogs
[23]. Despite of the hormonal postoperative changes, the
dogs had no other signs of pain. They all had good ap-
petite and ate normally when they were offered food
5 hours after surgery, which supports the fact that the
increase in cortisol and epinephrine levels was due to
stress not induced by pain.
If the analgesic efficacy for the pre- over the postoper-
ative administration was not proven advantageous, then
the lack of information about the potential intraopera-
tive adverse effects could preclude their preoperative use
[26]. One may choose to start the analgesic therapy with
NSAIDs at the end of surgery in order to prevent a pos-
sible increase in bleeding time intra-operatively [24,27].
However, since vedaprofen is known to be a preferential
cyclo-oxygenase-2 inhibitor in dogs [18], it would be
advantageous for causing less adverse effects than other
conventional NSAIDs, allowing long-term treatment
with low incidence of gastrointestinal and renal adverse
effects or on increase in bleeding time [28]. However,
controversial findings were reported on clinical studies
in dogs. A multicenter clinical trial reported that mild
and transient side effects, such as diarrhea, vomiting and
loss of appetite, were observed in 11% and severe side
effects, such as bloody diarrhea and/or repeated vomit-
ing, were observed in 5% of dogs with musculoskeletal
disorders receiving vedaprofen for 14 days [14]. Another
study described mild and transient side effects in 17.1%
of the dogs and treatment had to be stopped in 6.7% of
the dogs receiving vedaprofen for 56 days [13]. The inci-
dence of these adverse effects was similar to that found
with the meloxicam in both studies. In addition, in other
species, such as horses, vedaprofen was found to be
cyclo-oxygenase-1 selective in experimental studies [29],
although clinical studies in this species showed no such
adverse effects [30]. In the present study, although data
were not recorded during long-term treatment, adverse
effects were not observed in any dog during surgery or
within 24 hours of administration of vedaprofen.
Although the preventive analgesia concept supports
the assumption that blocking central sensitization re-
duces overall pain perception and duration, it is not
known, however, at which point is preventive inter-
vention most important, if it is blocking the nociceptive
input at surgery or blocking the postoperative pain re-
sulting from surgery in the immediate postoperative
period. A study in humans indicates that whether or not
the nociceptive input of surgery was blocked through
the administration of long acting local anesthesia, overall
postoperative pain perception was the same [31]. There-
fore, regardless of the timing of the vedaprofen ad-
ministration, both pre- and postoperative strategies are
ethically justified by their efficacy on pain relieve ob-
served in the present study.
Conclusions
In conclusion, the results of the present study showed
that vedaprofen had no preventive analgesic effect, since
the preoperative administration had no advantages over
the postoperative administration. However, both pre-
and postoperative vedaprofen given by the sublingual
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route were as effective as ketoprofen administered by
the intramuscular route for postoperative pain control in
dogs undergoing mandibulectomy and maxillectomy.
Methods
Animals
The study was approved by the Comissão de Ética no
Uso de Animais (CEUA; Ethics Committee on Animal
Use) of Faculdade de Medicina Veterinária e Zootecnia
from Universidade de São Paulo, under the protocol
#1667260314. Thirty client-owned dogs undergoing ma-
xillectomy or mandibulectomy for oral neoplasms re-
moval were evaluated. The minimum sample size for
paired data was calculated using power analysis and 10
dogs per group were required to have 95% chance (with
5% risk) to detect a difference of 2.5 mm in the pain
score between groups and considering a standard devia-
tion of 4 mm in the population. The study population of
the PRE group consisted of 5 males and 5 females,
comprising 4 mixed-breed dogs, 3 Poodles, 2 Cocker
Spaniels and 1 Maltese. In the POST group, there were 6
males and 4 females, which comprised 4 Poodles, 3
Cocker Spaniels, 2 mixed-breed dogs and 1 Airdale. In
the Control group, there were 6 males and 4 females,
which were 4 Poodles, 3 Cocker Spaniels, 2 mixed-breed
dogs and 1 Bichon Frise. Animals were only included in
the study if they had mandible or maxillary neoplasm
confirmed by clinical examination and other evaluations,
such as radiography, ultrasonography, tomography, cy-
tology or histopathology; if they were scheduled for
maxillectomy or mandibulectomy surgery in the morn-
ing period and; if no clinical cardiopulmonary, renal or
hepatic abnormalities were detected after a complete
physical examination, blood cell count and serum bio-
chemical analysis were performed. Animals were ex-
cluded from the study if they had a contraindication for
NSAIDs (i.e. clinical signs of gastrointestinal, hepatic or
renal disease). Client-consent was obtained before entry
of any dog into the study.
Anesthesia and surgery
Food was withheld for 12 hours and water for 4 hours
before anesthesia. All dogs received acepromazine
(0.05 mg.kg−1 IM; Acepran-Univet, São Paulo, Brazil)
as a pre-anesthetic medication and after 10 minutes, a
20-gauge catheter was fixed in the left cephalic vein for
intravenous (IV) administration of drugs and fluids.
Anesthesia was induced with propofol (5 mg.kg−1; Propovan,
Cristalia, Itapira, Brazil) administered slowly through the
IV catheter. After orotracheal intubation, anesthesia was
maintained with an end-tidal isoflurane concentration of
1.6-1.8% (Isoforine, Cristalia, Brazil) vaporized in 100%
oxygen via a semi-closed rebreathing circuit. A side-
stream gas analyzer (Multinex Plus, Datascope, New York,
USA) was connected between the endotracheal tube and
the Y-piece to measure the end-tidal isoflurane concentra-
tion, end-tidal carbon dioxide tension (ETCO2) and the fR.
Animals were allowed to breath spontaneously, unless
ETCO2 was not adequate (35–45 mmHg), in which case
mechanical ventilation could be used. The need for mech-
anical ventilation, if any, was registered. Heart rate and
rhythm, and NIBP were monitored with a multiparametric
data collection system (Viridia-M3, Hewllet Packard,
Germany). Fluid therapy with lactated Ringer’s solution
was infused at 10 mL.kg −1.hour−1 during anesthesia. An
18-gauge catheter was placed in the jugular vein of each
animal to facilitate blood sampling.
The surgical procedure was always performed by the
same senior surgeon, using the same resection pattern
and suture material for each surgery. Following surgery,
the dogs were extubated after laryngeal reflexes were re-
stored and then allowed to recover from anesthesia on a
heated mat in a cage. Duration of surgery and the time
between the disconnection of the orotracheal tube from
the anesthetic system and extubation were recorded. All
dogs were offered water ad libitum after recovery from
anesthesia. Soft or liquefied food was offered during the
period from 5 to 12 hours after surgery.
Study design
Animals randomly received one of the following treatments:
– Vedaprofen (0.5 mg.kg−1, sublingual; Quadrisol,
Boxmeer, Netherlands) at the time of premedication
(30 minutes before surgery) and saline at 10 minutes
prior to the end of surgery (PRE group; n = 10).
– Saline at the time of premedication (30 minutes
before surgery) and vedaprofen (0.5 mg.kg−1,
sublingual; Quadrisol, Boxmeer, Netherlands) at
10 minutes prior to the end of surgery (POST group;
n = 10)
– Saline at the time of premedication (30 minutes before
surgery) and ketoprofen (2 mg.kg−1 IM; Ketofen,
Rhodia-Merieux, Paulinia, Brazil) at 10 minutes prior
to the end of surgery (Control group; n = 10).
The reason to administer the drugs at 10 minutes be-
fore the end of the surgery was to ensure that they
would have enough time to be absorbed and that they
would have reached the adequate plasma concentration
by the time surgery was finished.
Randomization was performed using sealed numbered
envelopes. Drug preparation and administration, and
evaluations were blind.
Postoperative assessment
Analgesia was assessed using two scales: a 10-category
numerical rating scale (NRS; see Additional file 1) [28],
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in which 0 corresponds to no pain and 10 to a patient in
extreme pain; and the Colorado Pain Scoring System
(CPSS; see Additional file 2) [32], which ranges from 0
(no pain) to 4 (extreme pain). Pain was always scored by
the same blind observer during the study. Animals could
be rescued with morphine (0.1 mg.kg−1 IM) if NRS
scores were ≥4 and CPSS scores were ≥2. The total
number of rescue analgesic, if any, was recorded.
Adverse effects, such as vomiting, diarrhea and sedation
were recorded throughout a 24-hour observation period
after surgery. A sedation scale that ranged from 0 to 3 was
used, at which 0 = no sedation, no sensory or motor
deficits; 1 =mild sedation, slight sensory or motor deficits
evident as ataxia or disorientation; 2 =moderate sedation,
sternal recumbency and slight protrusion of the third eye-
lid; and 3 = strong sedation, lateral recumbency and ac-
centuated protrusion of the third eyelid [33].
Heart rate, MAP (oscillometric method), fR and rectal
temperature were recorded, in addition to the pain and
sedation scores, prior to premedication (baseline), im-
mediately after extubation and at 0.5 (30 minutes), 2.5,
4.5, 6, 20 and 24 hours after extubation. Dogs included
in the study were treated for as long as necessary, but
data for the study were recorded only up to 24 hours
after surgery.
Laboratory data
These data were measured in duplicate in the laboratory
of the Faculty and were performed at baseline, and at
30 min, 6 h and 24 h after extubation. Venous blood sam-
ples of 1.5 mL were collected from the jugular catheter to
measure cortisol and catecholamines (epinephrine, nor-
epinephrine and dopamine) levels. Samples to measure
cortisol were withdrawn in plastic syringes and transferred
to glass tubes, which were then centrifuged at 1500 rpm
for 10 minutes and frozen at −20°C for later analysis using
commercial immunoassay kits (Autodelfia Cortisol Kit,
Wallac, Finland). The detection limit for cortisol was
15 nmol.L−1, with a 1.4% interassay coefficient of variation
and a 3.1% intra-assay coefficient of variation. Blood sam-
ples to measure catecholamines were withdrawn using a
specific anticoagulant (glutathion + ethylene glycol tetra
acetic acid) and then immediately centrifuged at 3000 rpm
at 4°C for 10 minutes in a cold centrifuge (Model RT7,
Sorvall, California, USA). Resulting serum were then
stored at −80°C until analysis using high-performance
liquid chromatography (Model 460, Waters, São Paulo,
Brazil), according to the methodology described by
Krstulovic [34]. The intra-assay coefficients of variation
for the measurement of catecholamines in venous plasma
were 5.5% for both epinephrine and norepinephrine, and
the inter-assay coefficients were 6.8% for norepinephrine
and 7.9% for epinephrine. The limits of detection were
12.5 pg.mL−1 for both epinephrine and norepinephrine.
Statistical analysis
The physiologic data were analyzed by parametric exam-
ination within groups and between groups by using ana-
lysis of variance (ANOVA) for repeated measurements.
When appropriate, a post hoc analysis was performed
with the Tukey test. For nonparametric data, such as
NRS, CPSS and sedation scores, Friedman and Kruskal-
Wallis tests were employed followed by post hoc Dunn’s
test. The results were considered significant if P <0.05.
Additional files
Additional file 1: 10-category Numerical Rating Scale.
Additional file 2: Colorado State University Canine Acute Pain
Scale.
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